EICHORCondition: Solid Tumor · NSCLC · Sponsor: Allist Pharmaceuticals, Inc.
To evaluate the safety and tolerability of JAB-3312 administered in investigational regimens in adult participants with advanced solid tumors.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Must have histologically or cytologically confirmed metastatic or locally advanced solid tumor. Some cohorts must meet specific expression or gene mutation where indicated * Sufficient organ function * Participants must have at least 1 measurable lesion as defined by RECIST v1.1 * Must be able to provide an archived tumor sample * ECOG performance status score of 0 or 1. Exclusion Criteria: * History of cancer that is histologically distinct from the cancers under study * Active or untreated central nervous system (CNS) metastases * History of pneumonitis or interstitial lung disease (ILD) * Has active hepatitis B, hepatitis C infection, HIV * Any severe and/or uncontrolled medical conditions * LVEF ≤50% * QTcF \>470 msec
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Research Site | Phoenix, Arizona, United States | — |
| Research Site | Scottsdale, Arizona, United States | — |
| Research Site | Los Angeles, California, United States | — |
| Research Site | New Haven, Connecticut, United States | — |
| Research Site | Jacksonville, Florida, United States | — |
| Research Site | Orange City, Florida, United States | — |
| Research Site | Chicago, Illinois, United States | — |
| Research Site | Indianapolis, Indiana, United States | — |
| Research Site | Detroit, Michigan, United States | — |
| Research Site | Rochester, Minnesota, United States | — |
| Research Site | St Louis, Missouri, United States | — |
| Research Site | New York, New York, United States | — |
+ 3 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04720976